Found 6 results

Name Type of Offering Accepted Date
OCUCURE THERAPEUTICS INC
D 2015-10-06
Amount To Be Raised Indefinite
Associated Brokers / Dealers N/A
CIK Number 0001361004
Filed Document 0001361004-15-000001
Exclusions or Exemptions 506b
Accepted Date 2015-10-06
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business VIRGINIA
Revenue or Assets Decline to Disclose
Type of Security Equity
OCUCURE THERAPEUTICS INC
D 2014-02-26
Amount To Be Raised $500,000
Associated Brokers / Dealers N/A
CIK Number 0001361004
Filed Document 0001361004-14-000002
Exclusions or Exemptions 506b
Accepted Date 2014-02-26
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business VIRGINIA
Revenue or Assets Decline to Disclose
Type of Security Equity
OCUCURE THERAPEUTICS INC
D 2010-06-17
Amount To Be Raised $5,000,000
Associated Brokers / Dealers N/A
CIK Number 0001361004
Filed Document 0001361004-10-000003
Exclusions or Exemptions N/A
Accepted Date 2010-06-17
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business VIRGINIA
Revenue or Assets Decline to Disclose
Type of Security Equity
OCUCURE THERAPEUTICS INC
D 2011-06-21
Amount To Be Raised $2,569,999
Associated Brokers / Dealers N/A
CIK Number 0001361004
Filed Document 0001361004-11-000001
Exclusions or Exemptions N/A
Accepted Date 2011-06-21
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business VIRGINIA
Revenue or Assets Decline to Disclose
Type of Security Equity
OCUCURE THERAPEUTICS INC
D 2013-07-01
Amount To Be Raised $200,000
Associated Brokers / Dealers N/A
CIK Number 0001361004
Filed Document 0001361004-13-000001
Exclusions or Exemptions N/A
Accepted Date 2013-07-01
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business VIRGINIA
Revenue or Assets Decline to Disclose
Type of Security Equity
OCUCURE THERAPEUTICS INC
D 2017-05-04 11:20:34
Amount To Be Raised $100,002
Associated Brokers / Dealers N/A
CIK Number 0001361004
Filed Document 0001361004-17-000001
Exclusions or Exemptions 506b
Accepted Date 2017-05-04 11:20:34
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business VIRGINIA
Revenue or Assets Decline to Disclose
Type of Security Equity